Barie P S, Hydo L J
Department of Surgery, Cornell University Medical College, New York, NY, USA.
J Trauma. 1997 Oct;43(4):590-4; discussion 594-6. doi: 10.1097/00005373-199710000-00005.
Modern surgical care must meet high standards of quality but must also be cost-effective. Critical care uses huge amounts of resources, and strategies for effective use of scarce, expensive intensive care unit beds must be implemented. Previously, we demonstrated that ancillary expenditures can be decreased without compromising care. The present study was performed to determine whether our cost-containment strategies were durable and could be extended to areas, such as chest roentgenography, where savings previously proved elusive.
Costs for laboratory tests, radiographs, and drugs were determined prospectively for all surgical intensive care unit care for a 34-month period (January 1, 1994-October 31, 1996) at an urban university center. A systematic, multidisciplinary cost-reduction program began on May 1, 1994, with emphasis on laboratory and radiographic testing and procedures and drug therapies. Calendar-year cohorts were compared by age and Acute Physiology and Chronic Health Evaluation II and III admission scores. Outcome variables were hospital mortality, days in the intensive care unit and hospital, and expenditures. Cost data were taken weekly from the hospital's clinical information system.
All admission noncost variables were identical. There were significant reductions in intensive care unit and hospital length of stay, and there was a trend (p = 0.07) toward decreased hospital mortality. Normalized by the number of patient-days per week, arterial blood gas determinations were reduced 46% between 1994 and 1996, and nonarterial blood gas laboratory tests were reduced by 29% (both p < 0.0001). Within the latter group, electrolyte determinations decreased by 38% and serum creatinine determinations decreased by 32%. Chest roentgenograms decreased by 34%, but pharmaceutical costs decreased by a remarkable 73%.
Durable reductions in physician-ordered ancillary expenditures are possible without compromising the standard of care of critically ill patients, but active management and daily reinforcement are necessary to the process. Shorter length of stay and lower costs benefit the patient, the surgeon, the intensivist, and the institution.
现代外科护理必须达到高标准的质量,但也必须具有成本效益。重症监护消耗大量资源,因此必须实施有效利用稀缺且昂贵的重症监护病房床位的策略。此前,我们证明了在不影响护理质量的情况下可以减少辅助支出。本研究旨在确定我们的成本控制策略是否持久,以及是否可以扩展到胸部X线摄影等此前难以实现成本节约的领域。
前瞻性地确定了一所城市大学中心在34个月期间(1994年1月1日至1996年10月31日)所有外科重症监护病房护理的实验室检查、X线片和药品费用。1994年5月1日开始了一项系统的多学科成本降低计划,重点是实验室和影像学检查及操作以及药物治疗。按年龄以及急性生理学与慢性健康状况评价II和III入院评分对历年队列进行比较。结果变量包括医院死亡率、重症监护病房和医院住院天数以及支出。成本数据每周从医院的临床信息系统获取。
所有入院时的非成本变量均相同。重症监护病房和医院住院时间显著缩短,且医院死亡率有下降趋势(p = 0.07)。按每周患者天数进行标准化后,1994年至1996年期间动脉血气测定减少了46%,非动脉血气实验室检查减少了29%(均p < 0.0001)。在后一组中,电解质测定减少了38%,血清肌酐测定减少了32%。胸部X线片减少了34%,但药品费用显著减少了73%。
在不影响重症患者护理标准的情况下,有可能持久降低医生开具的辅助支出,但该过程需要积极管理和每日强化。缩短住院时间和降低成本对患者、外科医生、重症监护医生和机构都有益。